KOSDAQ · Healthcare · ₩96B
₩2,750-2.31%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 7.2% · as of 26.09.11
Among 36 신약 개발 peers
Quarterly Revenue Growth
“신약 개발 진전과 새 매출원이 다음 성장을 준비하고 있어요.”
In the company's words · 2026 2분기 filing